Jakafi — Medical Mutual
Pediatric Acute Lymphoblastic Leukemia
Initial criteria
- Patient is age ≥ 12 years
- Patient has steroid-refractory disease
- Prescribed by or in consultation with a hematologist or oncologist
Approval duration
1 year
Pediatric Acute Lymphoblastic Leukemia
1 year